Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
46 /100
MEDIUM RISK
Score updated Oct 13, 2026

GDTC — CytoMed Therapeutics Limited Dilution Risk Tracker

Track GDTC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GDTC — Get alerts when the score changes →

As of October 13, 2026, CytoMed Therapeutics Limited (GDTC) has a DilutionWatch DilutionScore of 46/100, rated MEDIUM dilution risk. CytoMed Therapeutics Limited has a market capitalization of $9.59M, 11.83M shares outstanding, 3 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
77
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split model est. 30%
• 50-day avg $1.02 approaching $1 threshold
🔔 Track GDTC — Get forecast alerts →

Market Data

Market Cap$9.59M
Shares Outstanding11.83M
Float1.84M
Cash$1.64M
Debt$378.1K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore46/100DilutionWatch score record
Shares Outstanding11.83MVerified float table or market cache
Public Float1.84MVerified float table or market cache
Market Cap$9.59MMarket data cache
Cash RunwayNot availableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 0.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 69.2% shares (2026Q1 vs prior)
3 institutional holders · 16.3K shares
#1 XTX Topco Ltd 10.1K shares
#2 UBS Group AG 6.2K shares
#3 OSAIC HOLDINGS, INC. 21 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest17.1K
Days to Cover1.1
% of Float0.9%
FINRA data as of Sep 30, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news available for this ticker.

DilutionScore History — Last 90 Days

GDTC's DilutionScore is currently 46/100 (Medium risk), with 1 score change tracked over 90 days. The score deteriorated from 49/100 (Medium risk).

Period Score Risk Level Duration
Aug 14 – Oct 13, 202646/100MEDIUM61 days
Jul 16 – Aug 13, 202649/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

GDTC shares outstanding have increased 0.8% from 11.73M (Feb 2026) to 11.83M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 30, 202611.83M1.84M▼ 53.02%
May 29, 202611.83M3.91M▼ 0.10%
May 18, 202611.83M3.92M▼ 1.36%
Apr 24, 202611.83M3.97M▲ 0.07%
Apr 11, 202611.83M3.97M▲ 5.21%
Apr 03, 202611.73M3.77M▲ 2.50%
Feb 14, 202611.73M3.68M—
Feb 13, 202611.73M3.68M—
Feb 12, 202611.73M3.68M—

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track GDTC Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment GDTC files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking GDTC — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for GDTC
GDTC FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.